e-learning
resources
Berlin 2008
Wednesday, 08.10.2008
Inorganic dust exposure and the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Measuring pulmonary compliance in patients with asbestos-induced visceral pleural fibrosis or asbestosis using new reference equations
X. Baur, W. Raab, A. Preisser, L. Barbinova, W. Galetke, J. Schneider (Hamburg, Bad Reichenhall, Sollingen, Giessen, Germany)
Source:
Annual Congress 2008 - Inorganic dust exposure and the lung
Session:
Inorganic dust exposure and the lung
Session type:
E-Communication Session
Number:
4465
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Baur, W. Raab, A. Preisser, L. Barbinova, W. Galetke, J. Schneider (Hamburg, Bad Reichenhall, Sollingen, Giessen, Germany). Measuring pulmonary compliance in patients with asbestos-induced visceral pleural fibrosis or asbestosis using new reference equations. Eur Respir J 2008; 32: Suppl. 52, 4465
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Pleural plaques and lung function in asbestos-exposed workers free from pulmonary fibrosis
Source: Annual Congress 2011 - Mineral dusts
Year: 2011
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysema
Source: ERJ Open Res, 7 (3) 00316-2021; 10.1183/23120541.00316-2021
Year: 2021
Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestos-related disorders (ARDs)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015
Diffuse pulmonary fibrosis and pulmonary emphysema associated with paradoxically normal spirometry
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006
Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 359-365
Year: 2012
Subtypes of pulmonary emphysema on HRCT affect prognosis on combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same?
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Lung sounds in patients with asbestos-associated pleural fibrosis, asbestosis or other lung fibrosis, objectified with
vibration response imaging
Source: Annual Congress 2008 - Inorganic dust exposure and the lung
Year: 2008
The impact of emphysema in pulmonary fibrosis
Source: Eur Respir Rev 2013; 22: 153-157
Year: 2013
The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
Static and dynamic lung compliance in patients with pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Comparison of clinical features between patients of lung cancer with combined pulmonary fibrosis and emphysema syndrome and those with interstitial pneumonia
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Pleural pathology and lung fibrosis in patients with retroperitoneal fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 146s
Year: 2004
The difference of lung mechanics and chest kinematics in pulmonary rehabilitation of interstitial lung diseases versus idiopathic pulmonary fibrosis
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Predictive systemic biomarkers of pulmonary fibrosis after COVID-19 pneumonia
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Does emphysema coexistence with IPF change prognosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015
Coexistent pulmonary emphysema delays the decrease in vital capacity in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE)
Source: International Congress 2014 – ILDs 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept